Literature DB >> 21276318

Superior vena cava syndrome in thoracic malignancies.

Philipp M Lepper1, Sebastian R Ott, Hanno Hoppe, Christian Schumann, Uz Stammberger, Antonio Bugalho, Steffen Frese, Michael Schmücking, Norbert M Blumstein, Nicolas Diehm, Robert Bals, Jürg Hamacher.   

Abstract

The superior vena cava syndrome (SVCS) comprises various symptoms due to occlusion of the SVC, which can be easily obstructed by pathological conditions (eg, lung cancer, due to the low internal venous pressure within rigid structures of the thorax [trachea, right bronchus, aorta]). The resulting increased venous pressure in the upper body may cause edema of the head, neck, and upper extremities, often associated with cyanosis, plethora, and distended subcutaneous vessels. Despite the often striking clinical presentation, SVCS itself is usually not a life-threatening condition. Currently, randomized controlled trials on many clinically important aspects of SVCS are lacking. This review gives an interdisciplinary overview of the pathophysiology, etiology, clinical manifestations, diagnosis, and treatment of malignant SVCS.

Entities:  

Mesh:

Year:  2011        PMID: 21276318     DOI: 10.4187/respcare.00947

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  26 in total

1.  Superior vena cava syndrome associated with longstanding implantable central venous port.

Authors:  Paulina Krzemien Santos; Ana Margarida Fernandes; Vanessa Figueiredo; Sérgio Janeiro
Journal:  BMJ Case Rep       Date:  2015-01-27

Review 2.  Percutaneous management of chronic central venous occlusive disease.

Authors:  Matthew G Gipson; Rajan K Gupta; Mitchell T Smith
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

3.  Stent insertion for malignant superior vena cava syndrome: effectiveness and long-term outcome.

Authors:  Su Niu; Yuan-Shun Xu; Long Cheng; Chi Cao
Journal:  Radiol Med       Date:  2017-04-20       Impact factor: 3.469

4.  Invasive thymoma presenting as classic superior vena cava syndrome: a case of venous spread metastasis.

Authors:  Prasan Kumar Panda; Naveet Wig; Sanjeev Kumar; Sudheer Arava
Journal:  BMJ Case Rep       Date:  2016-10-26

5.  Multiple disappearing spinal lesions.

Authors:  Daniel Walker; Zaid Jibri
Journal:  Skeletal Radiol       Date:  2020-03       Impact factor: 2.199

6.  Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?

Authors:  Bei-Ning Wang; Yu-Xi Li; Wei Ma; Song-Yun Chu; Zhi-Hao Liu; Wen-Hui Ding; Jian-Ping Li
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

7.  An 82-year-old man with recurrent angioedema.

Authors:  Charles F Schuler; Elisabeth A Pedersen; Marc S McMorris
Journal:  Allergy Asthma Proc       Date:  2019-09-01       Impact factor: 2.587

8.  Benign superior vena cava syndrome with uncontrolled pleural effusion by calcified mediastinal lymphadenopathy: surgical management.

Authors:  Yoon Pyo Lee; Eun Mi Chun; Yoo Kyung Kim; Kwan Chang Kim
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

9.  Worsening of Obstructive Sleep Apnea Associated with Catheter-Related Superior Vena Cava Syndrome.

Authors:  Marie Jouvenot; Serge Willoteaux; Nicole Meslier; Frédéric Gagnadoux
Journal:  J Clin Sleep Med       Date:  2015-06-15       Impact factor: 4.062

Review 10.  Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond.

Authors:  Tamir Friedman; Keith B Quencer; Sirish A Kishore; Ronald S Winokur; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.